Apparent treatment-resistant hypertension – patient–physician relationship and ethical issues
- 12 January 2017
- journal article
- review article
- Published by Taylor & Francis in Blood Pressure
- Vol. 26 (3) , 133-138
Abstract
Poor drug adherence is a major cause of apparent treatment-resistant hypertension. As a consequence, several methods have been developed and attempted implemented in clinical practice to reveal non-adherence and to monitor drug adherence. There are, however, several hitherto unresolved ethical aspects regarding potential methods for drug monitoring in these patients. The most striking challenge is the balance between patient autonomy and the physician's desire for the patient to adhere to the prescribed therapy. Also, methods for monitoring must only be implemented in the treatment of well-informed and consenting patients. Major resources are used on non-adherent patients; how long the physician should encourage continuation of treatment is an important question. We believe that physicians should reflect and discuss these potential challenges, and that patient education, information and a solid patient-physician relationship are essential for achieving drug adherence. Methods for monitoring adherence represent, however, a useful and often necessary supplement.Keywords
This publication has 23 references indexed in Scilit:
- Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant HypertensionHypertension, 2016
- Tertiary work-up of apparent treatment-resistant hypertensionBlood Pressure, 2016
- Adherence to medication and drug monitoring in apparent treatment-resistant hypertensionBlood Pressure, 2016
- Eligibility for Renal DenervationHypertension, 2014
- Adjusted Drug Treatment Is Superior to Renal Sympathetic Denervation in Patients With True Treatment-Resistant HypertensionHypertension, 2014
- Therapeutic Drug Monitoring Facilitates Blood Pressure Control in Resistant HypertensionJACC, 2014
- Resistant Hypertension: Diagnosis, Evaluation, and TreatmentHypertension, 2008
- Ethical issues of compliance/adherence in the treatment of hypertensionAdvances in Chronic Kidney Disease, 2004
- Interventions to Enhance Patient Adherence to Medication PrescriptionsJAMA, 2002
- Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisionsJournal Of Hypertension, 2001